title: GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: A
authors.initials: A
authors.lastname: Nazha
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: L
authors.initials: L
authors.lastname: Rybicki
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: D
authors.initials: D
authors.lastname: Abounader
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: B
authors.initials: B
authors.lastname: Bolwell
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: R
authors.initials: R
authors.lastname: Dean
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: A T
authors.initials: AT
authors.lastname: Gerds
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: D
authors.initials: D
authors.lastname: Jagadeesh
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: B K
authors.initials: BK
authors.lastname: Hamilton
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: B T
authors.initials: BT
authors.lastname: Hill
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kalaycio
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: H
authors.initials: H
authors.lastname: Liu
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: B
authors.initials: B
authors.lastname: Pohlman
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: R
authors.initials: R
authors.lastname: Sobecks
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Sekeres
authors.affiliation: Department of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
authors.forename: N S
authors.initials: NS
authors.lastname: Majhail
mesh_terms: D000367:Age Factors; D000368:Aged; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006680:HLA Antigens / Q000737:chemistry; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D053208:Kaplan-Meier Estimate; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D015477:Leukemia, Myelomonocytic, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009364:Neoplasm Recurrence, Local; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous / Q000379:methods; D016896:Treatment Outcome
chemical_list: D006680:HLA Antigens